From: Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC
 | n | LCMR1 expression | P | |
---|---|---|---|---|
 |  | Negative | Positive |  |
Gender | Â | Â | Â | Â |
   Male | 61 | 12 | 49 | 0.147 |
   Female | 23 | 8 | 15 |  |
Age(y) | Â | Â | Â | Â |
   ≥65 | 22 | 4 | 18 | 0.471 |
   <65 | 62 | 16 | 46 |  |
Smoking status | Â | Â | Â | Â |
   Yes | 45 | 10 | 35 | 0.714 |
   No | 39 | 10 | 29 |  |
Pathological type | Â | Â | Â | Â |
   Adenocarcinoma | 41 | 10 | 31 | 0.614 |
   Squamous cell carcinoma | 40 | 10 | 30 |  |
   Adenosquamous carcinoma | 3 | 0 | 3 |  |
Histologic grade | Â | Â | Â | Â |
   PD | 28 | 6 | 22 | 0.918 |
   MD | 45 | 11 | 34 |  |
   WD | 11 | 3 | 8 |  |
Lymph node metastasis | Â | Â | Â | Â |
   Yes | 62 | 12 | 50 | 0.108 |
   No | 22 | 8 | 14 |  |
Clinical stage | Â | Â | Â | Â |
   I-II | 40 | 14 | 26 | 0.022 |
   III-IV | 44 | 6 | 38 |  |